Meta Pixel

News and Announcements

You’ve been raising capital for more than three months – what’s wrong with your deal?

  • Published May 07, 2023 11:00PM UTC
  • Publisher Steve Torso
  • Categories Capital Raising Tips

Does this question sound familiar? It’s a common concern for founders and startups, but it’s time to reframe the conversation around capital raising.

As someone who has witnessed the struggles of founders firsthand and navigated the process myself, I’ve discovered that raising capital is simply a marketing and sales exercise. Here’s how to plan for your next capital raise and set yourself up for success:

Embrace the timeline: Capital raising can take anywhere from 6 to 24 months, and that’s perfectly normal. Blackbird Ventures, for example, took 22 months to raise their first fund, meeting with over 500 investors to secure 97 backers and raise $27 million.

Generate interest early: Start building relationships and attracting potential investors well before launching your capital raise. A wise industry panellist once said, “You need to be either raising capital or raising friends.”

Set performance KPIs: Establish clear goals for your capital raising efforts, such as getting 50 investors into your deal room within 2 to 3 months and communicating with them at least four times a year.

Analyse your performance: Continuously assess your capital raising process, documentation, and interactions with investors. Treat this process like you would your business development team, with the understanding that your company is the product.

By following these steps, you’ll be better prepared for the capital raising process and avoid common pitfalls. Remember that raising capital is a long-term endeavour, and a strategic approach is key to securing the investment your startup needs to thrive.

Company Updates
The Biofilm Breakthrough: How An Australian BioTech Firm Is Tapping Indonesia’s $45,000-a-Kitchen Bottleneck

Australian sustainability and deep-tech firm Altair International Pty Ltd is commercialising plant-based clinical hygiene technology, targeting a prime operational bottleneck in Indonesia’s massive national free meals program. Every few years, an Australian deep-tech company emerges combining proprietary science with a transformational anchor contract, the kind of business that quietly creates an entirely new market category […]

Capital Insights
THE TAX CHANGED. NOW THE PRODUCT IS CHANGING TO MATCH.

Changes to the 50% capital gains tax discount are shifting Australian private capital away from growth and into high-yielding wrappers. Fund managers are actively redesigning products across private credit and property to capture the incoming capital rotation

Capital Insights
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula

Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.

Join over 45,000+ sophisticated investors

Join Now